Other
Paul Scherrer Institut, Center for Proton Therapy
Total Trials
3
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed trials have results
Key Signals
2 recruiting
Enrollment Performance
Analytics
Phase 3
1(33.3%)
N/A
1(33.3%)
Phase 2
1(33.3%)
3Total
Phase 3(1)
N/A(1)
Phase 2(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT06335888Phase 2Recruiting
A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis
Role: collaborator
NCT05055648Phase 3Recruiting
PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
Role: collaborator
NCT03669341Not ApplicableCompleted
Assessment of 2 Different Techniques for Suppression of Respiratory Motion in Lung Cancer Treatment With Proton Therapy Using Magnetic Resonance Imaging (MRI)
Role: lead
All 3 trials loaded